| Jay M Gonzalez, DO | |
|
2700 W 9th Ave, Ste 230, Oshkosh, WI 54904-7247 | |
| (920) 223-0220 | |
| Not Available |
| Full Name | Jay M Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 2700 W 9th Ave, Oshkosh, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396739488 | NPI | - | NPPES |
| 43514100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 46930 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agnesian Healthcare Inc | 1658289624 | 319 |
News Archive
Revenue-driven surgery and poor planning drive some surgical patients home too early, concludes a pair of logistical studies conducted by researchers at the University of Maryland's Robert H. Smith School of Business.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
Some hospitals are suing Massachusetts' Medicaid program for underpaying. Idaho health agencies are broadening their own lawsuit against the state on Medicaid payment rules.
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting severe middle ear infections, based on results of a study done in mice by investigators from St. Jude and The Rockefeller University.
› Verified 3 days ago
| Entity Name | Agnesian Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
Revenue-driven surgery and poor planning drive some surgical patients home too early, concludes a pair of logistical studies conducted by researchers at the University of Maryland's Robert H. Smith School of Business.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
Some hospitals are suing Massachusetts' Medicaid program for underpaying. Idaho health agencies are broadening their own lawsuit against the state on Medicaid payment rules.
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting severe middle ear infections, based on results of a study done in mice by investigators from St. Jude and The Rockefeller University.
› Verified 3 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
Revenue-driven surgery and poor planning drive some surgical patients home too early, concludes a pair of logistical studies conducted by researchers at the University of Maryland's Robert H. Smith School of Business.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
Some hospitals are suing Massachusetts' Medicaid program for underpaying. Idaho health agencies are broadening their own lawsuit against the state on Medicaid payment rules.
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting severe middle ear infections, based on results of a study done in mice by investigators from St. Jude and The Rockefeller University.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay M Gonzalez, DO 2700 W 9th Ave, Ste 230, Oshkosh, WI 54904-7247 Ph: (920) 223-0220 | Jay M Gonzalez, DO 2700 W 9th Ave, Ste 230, Oshkosh, WI 54904-7247 Ph: (920) 223-0220 |
News Archive
Revenue-driven surgery and poor planning drive some surgical patients home too early, concludes a pair of logistical studies conducted by researchers at the University of Maryland's Robert H. Smith School of Business.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
Merck Canada announced today a $6.8 million investment in AmorChem, a Quebec life sciences venture capital fund. This is the latest investment made by Merck following a commitment made in 2010 to invest an incremental $100 million over five years in biopharmaceutical research and development in Quebec.
Some hospitals are suing Massachusetts' Medicaid program for underpaying. Idaho health agencies are broadening their own lawsuit against the state on Medicaid payment rules.
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting severe middle ear infections, based on results of a study done in mice by investigators from St. Jude and The Rockefeller University.
› Verified 3 days ago
Dr. Sheila M Anderson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 414 Doctors Ct, Oshkosh, WI 54901 Phone: 920-303-8700 Fax: 920-303-5150 | |
Dr. Robert J Holly, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 Fax: 920-456-7801 | |
Dr. Jessica L Nokovic, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 | |
Dr. Douglas J Henke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 | |
Dr. Kara Tweadey Bos, M.D., M.P.H Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2700 W 9th Ave Ste 230, Oshkosh, WI 54904 Phone: 920-223-0220 |